Rasio utang jangka cendhak marang ekuitas: Avenue Therapeutics (ATXI)
The prospects for Avenue Therapeutics (ATXI) depend on regulatory verdicts regarding new analgesics and legal safety aspects. This daily price action, visualized for analytical convenience, reflects a metric of 0.00. Such high volatility is driven by the venture nature of the development portfolio. Meanwhile, the business focuses on creating non-opioid treatments for acute pain, which remains critical amid the global opioid crisis.
Rincian analitis perusahaan Avenue Therapeutics
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Avenue Therapeutics|ATXI - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Avenue Therapeutics, Inc.|ATXI - Utang perusahaan|Utang-utang marang kapitalisasi buku Avenue Therapeutics Inc.|ATXI - Utang jangka dawa|Utang jangka cendhak perusahaan Avenue Therapeutics|Indikator likuiditas cepet avenuetx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis umum perusahaan:Avenue Therapeutics, Inc
Professional managers filter assets by analyzing debt loads, utilizing the ratio of short-term liabilities (over one year) to equity to assess financial stability and liquidity risks. For Avenue Therapeutics (ATXI), whose model relies on costly outsourcing of compound synthesis via CMOs, this chart of short-term loan share relative to equity is critical for monitoring the company's ability to service vendor contracts.
Pesaing Avenue Therapeutics (ATXI)
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal denalitherapeutics.com|Rasio utang jangka cendhak marang ekuitas HRMY (Harmony Biosciences Holdings, Inc.)|Utang jangka cendhak marang ekuitas BHVN (Biohaven Ltd)|Utang jangka cendhak marang modal AMLX (Amylyx)|Trevi Corp (TRVI) - Kewajiban jangka cendhak marang modal|PRAX - Utang jangka cendhak marang ekuitas|AVXL (anavex.com) - Rasio utang jangka cendhak marang modal|CBLL (CeriBell) - Rasio utang jangka cendhak marang ekuitas|Prothena Biosciences (PRTA) - Utang jangka cendhak marang modal|ALEC (Alector Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Annexon Biosciences Inc. ANNX|Rasio utang jangka cendhak marang ekuitas OMER (Omeros Corporation)|NGNE (neurogene.com) - Rasio tanggungan utang jangka cendhak marang modal|AC Immune SA - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal VYGR (Voyager Therapeutics Inc)|Neumora Therapeutics Inc - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal SCLX (Scilex Holding Company, Inc.)|TVGN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Alpha Cognition Inc. (ACOG)|Utang jangka cendhak marang ekuitas Cognition Therapeutics, Inc.|IKT: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal SAVA|Utang jangka cendhak marang modal assertiotx.com (ASRT)|Utang jangka cendhak marang ekuitas Coya Therapeutics COYA|VTGN (VistaGen Therapeutics, Inc.) - Kewajiban jangka cendhak marang ekuitas|Ovid Rx - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Acumen Pharmaceuticals Inc.|CRVO (CervoMed Inc) - Rasio utang jangka cendhak marang ekuitas|Alterity Therapeutics Limited (ATHE) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas CLNN|PEPG (PepGen Corp) - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang modal JUNS|Koefisien utang jangka cendhak marang modal Relmada Therapeutics Inc|Utang jangka cendhak marang modal ANVS (Annovis Bio Corp)|GRCE - Rasio utang jangka cendhak marang ekuitas|AIFF - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Klotho Neurosciences Inc KLTO|NRSN: Utang jangka cendhak marang modal|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas MTVA|NRXS (NeurAxis Inc) - Rasio silihan jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas HSDT (Helius Medical)|passagebio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal NEUP (Neuphoria Therapeutics)|Koefisien utang jangka cendhak marang modal Minerva Neurosciences Inc (NERV)|ATHA - Utang jangka cendhak marang ekuitas|ADXN (Addex) - Rasio utang jangka cendhak marang modal|ALZN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Cyclerion Therapeutics, Inc. (CYCN)|Rasio utang jangka cendhak marang ekuitas PTIX|Utang jangka cendhak marang modal Pasithea|Utang jangka cendhak marang ekuitas Cortigent, Inc. (CRGT)|BCLI (BrainStorm Cell Therapeutics Inc.) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|chromocell.com (CHRO) - Kewajiban jangka cendhak marang modal|Eliem - Utang jangka cendhak marang modal|ITCI - Utang jangka cendhak marang modal|LBPH (Longboard Pharma) - Rasio utang jangka cendhak marang ekuitas|MRNS (Marinus Pharma) - Utang jangka cendhak marang ekuitas|NKGN (NKGen Biotech, Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal neurobopharma.com NRBO|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|Synaptogenix Inc. - Rasio utang jangka cendhak marang modal|Trevena, Inc - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Vigil Neuroscience Inc. VIGL|Anew Medical, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cerevel.com